etomidate has been researched along with Adrenal Cortex Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallin, H; Husain, SS; Jeffrey, S; Pejo, E; Raines, DE; Santer, P | 1 |
| Cotten, JF; Forman, SA; Husain, SS; Kelly, EW; Miller, KW; Nguyen, HH; Raines, DE | 1 |
2 other study(ies) available for etomidate and Adrenal Cortex Diseases
| Article | Year |
|---|---|
Analogues of etomidate: modifications around etomidate's chiral carbon and the impact on in vitro and in vivo pharmacology.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Anesthetics, Intravenous; Animals; Carbon; Etomidate; Female; GABA Agonists; Hypnotics and Sedatives; Indicators and Reagents; Lethal Dose 50; Male; Molecular Conformation; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Solubility; Stereoisomerism; Structure-Activity Relationship; Xenopus laevis | 2014 |
Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.
Topics: Adrenal Cortex Diseases; Adrenal Cortex Hormones; Anesthetics, Intravenous; Animals; Biotransformation; Dose-Response Relationship, Drug; Electrophysiology; Esterases; Etomidate; Half-Life; Hemodynamics; Humans; In Vitro Techniques; Larva; Male; Postural Balance; Propofol; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Structure-Activity Relationship; Xenopus laevis | 2009 |